Lack of correlation between elevated maternal serum hCG during second-trimester biochemical screening and fetal congenital anomaly

• Published in: Prenatal diagnosis 2005-03, Vol.25 (3), p.220-224
• Main Authors: Celentano, Claudio, Guanciali-Franchi, Paolo Emilio, Liberati, Marco, Palka, Chiara, Fantasia, Donatella, Morizio, Elisena, Calabrese, Giuseppe, Stuppia, Liborio, Rotmensch, Siegfried
• Format: Article
• Language: English
• Subjects: Adult; Biological and medical sciences; Birth control; Chorionic Gonadotropin - blood; Congenital Abnormalities - blood; congenital anomaly risk; elevated serum hCG; Female; Fetal Diseases - blood; Gynecology. Andrology. Obstetrics; Hormonal contraception; Humans; Mass Screening; Medical sciences; Pregnancy; Pregnancy Trimester, Second
• ISSN: 0197-3851; 1097-0223
• DOI: 10.1002/pd.1110

Objective Isolated elevations in midtrimester maternal serum human chorionic gonadotrophin concentrations (MShCG) have been reported to be associated with a substantially increased likelihood of fetal congenital malformations. The reported malformations included a wide range of organ systems, originating at different embryologic developmental stages. The purpose of our study was to determine the significance of an isolated elevated MShCG (>2.5 MoM) in midtrimester for the detection of fetal structural anomalies in a large population. Methods Among 10 144 women who underwent a biochemical triple screen at 15 to 18 weeks' gestation, 463 patients, who had an elevated MShCG, but normal α‐fetoprotein (AFP) and unconjugated estriol (uE3) levels, were identified. Patients with an integrated calculated Down syndrome risk above 1:250 were excluded. Only nonsmokers, at ages